Atlas Trials

High-dose vs. Standard-dose Cephalexin for Cellulitis

Clinical trial NCT04471246 · COMPLETED

Trial details

NCT number
NCT04471246
Sponsor
Ottawa Hospital Research Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cellulitis
Start date
2021-08-16
Primary completion
2022-02-23
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.